DR. DANIEL W. BENSON, MD

Plain English
This research looked at a potential treatment for cystic fibrosis patients with a specific type of genetic mutation that prevents them from producing a functioning protein needed for healthy lung function. The study found that a drug called G418 helped create functional versions of the protein in many patients, especially those with the UGA mutation, and some of these proteins worked almost as well as normal ones. This is important because it shows that combining this therapy with existing treatments might significantly improve health outcomes for these patients. Who this helps: This research primarily helps cystic fibrosis patients with nonsense mutations.

Plain English
This study focused on creating a large-animal model of atrial fibrillation (AFib) using Yucatan miniswine, as AFib is a major heart condition affecting many adults in the U.S. The researchers successfully induced persistent AFib in 4 out of 6 pigs over about 80 days and found that the animals showed decreased activity levels and health after the condition developed. This model will help in testing new treatments for AFib, which currently affects a significant number of patients without effective cures. Who this helps: This benefits patients suffering from atrial fibrillation and doctors seeking better treatment options.

Plain English
This study looked at how well the Nottingham Hip Fracture Score (NHFS) can predict the risk of dying within 30 days and one year after a certain type of leg fracture (distal femur fractures) that are common in older adults. They found that 7.1% of high-risk patients (those with an NHFS of 5 or more) died within 30 days, while no low-risk patients died, and 37.8% of high-risk patients died within a year compared to only 6.4% of low-risk patients. This information is important because it helps doctors identify patients who are at greater risk of mortality, allowing for better treatment planning and communication with patients and their families. Who this helps: This helps patients and doctors by improving understanding of risks associated with fragility fractures.

Plain English
This study looked at how certain chemicals known as PFAS (like PFOS and PFOA) affect brain cells linked to dopamine, which is important for movement and mood, as seen in Parkinson's disease. Researchers found that PFOS was the most harmful, causing significant damage to these cells and leading to behavioral issues in tests. This is important because it helps identify toxic substances that could be contributing to neurodegeneration, allowing for better environmental safety measures. Who this helps: This benefits patients at risk for Parkinson’s disease and environmental health advocates.

Plain English
This study looked at a serious complication called reversible cerebral vasoconstriction syndrome (RCVS) that occurred in a 63-year-old woman after she received a treatment for relapsed multiple myeloma. After the treatment, she experienced severe headaches and weakness, which led to strokes visible in brain scans. By 69 days later, while some damage in her brain had resolved, she still faced significant neurological challenges, highlighting the need for doctors to be aware of this complication when treating multiple myeloma with CAR-T therapy. Who this helps: This information benefits doctors and patients undergoing CAR-T therapy for multiple myeloma.

Plain English
This study looked at gunshot wounds that caused fractures in a specific part of the spine, known as the atlantoaxial spine (the first two vertebrae in the neck). Out of 36 patients analyzed, 86% were male with an average age of 30 years. The research found that 66% of these patients also had serious vascular injuries, and those with significant neurological issues at the start usually did not see any improvement, highlighting the need for specialized medical care during treatment. Who this helps: This information benefits doctors and medical teams caring for patients with gunshot wounds to the spine.

Plain English
This study looked at how often patients with two spine conditions, diffuse idiopathic skeletal hyperostosis (DISH) and cervical ossification of the posterior longitudinal ligament (cOPLL), occur together in the U.S. Researchers found that among 29,076 cOPLL patients, only 681 (1.4%) also had DISH, but those with DISH underwent surgery more often (30.2%) than those without DISH (21.7%). While the overall short-term risks after surgery were similar for both groups, patients with DISH had a higher rate of neurological injuries (14.7% compared to 6.9%), which could indicate more complex health issues. Who this helps: This information benefits doctors who treat spine conditions and helps identify patient groups at higher risk for complications.

Plain English
This study tested a new treatment called modakafusp alfa for patients with multiple myeloma, a type of blood cancer that has not responded to standard therapies. Out of 106 patients, 43.3% responded positively to the treatment, with their response lasting an average of 15.1 months. It is important because it shows that modakafusp alfa can activate the immune system to fight the cancer, even in patients who have already undergone many prior treatments, although almost all patients experienced some serious side effects like low blood cell counts. Who this helps: This helps patients with hard-to-treat multiple myeloma.

Plain English
This study looked at how college programs in animal and poultry science can better prepare students for jobs in the poultry industry, which is changing to meet global challenges. The researchers found that employers want graduates with skills to tackle both local and international issues, highlighting the need for hands-on experience and teamwork. This matters because equipping students with the right skills will help them succeed in a competitive job market. Who this helps: This benefits students and future employees in the poultry industry.

Plain English
This research paper looks at different diseases that cause inflammation of the blood vessels in the lungs, known as pulmonary vasculitis. It highlights that many of these conditions share similar imaging features, especially with another lung problem called alveolar hemorrhage, which is often seen in these cases. Understanding these imaging findings is crucial for doctors to diagnose these diseases accurately, as a collaborative effort is needed for effective treatment. Who this helps: This helps doctors and radiologists in diagnosing lung conditions.

Plain English
This study looked at how HIV affects patients undergoing surgery for degenerative cervical myelopathy (DCM), a condition affecting the spinal cord. Researchers found that patients with HIV had surgery at a younger age (about 54 years old) compared to those without HIV (about 57 years old) and experienced higher rates of infections and neurological problems shortly after surgery. However, both groups had similar rates of needing additional surgeries within two years after the first operation. Who this helps: This information benefits patients with HIV and their doctors by highlighting their specific surgical risks and outcomes.

Plain English
This study looked at how well routine contrasted chest CT scans can locate a specific artery (the angular branch of the thoracodorsal trunk) before surgery for patients who need a type of shoulder reconstruction called a scapular flap. Among 11 patients, the CT scans accurately identified the artery 81.8% of the time, with a maximum accuracy deviation of only 2 mm compared to what was found during surgery. This is important because it helps surgeons plan better for operations, which can lead to fewer complications and improved outcomes. Who this helps: This helps patients undergoing shoulder reconstruction surgery.

Plain English
This study looked at how climate change is affecting vulnerable communities in coastal Bangladesh, specifically focusing on the issue of waterlogging caused by external development projects. Researchers found that marginalized groups face severe hardships such as lower crop yields, loss of livestock, unemployment, rising prices, and health issues due to their exclusion from decisions about adaptation strategies. This matters because addressing these injustices can lead to better management of resources and improved resilience for these communities. Who this helps: This helps marginalized communities in coastal Bangladesh.

Plain English
This study looked at how a combined treatment of Cognitive Behavioral Therapy and Acceptance and Commitment Therapy can help improve sleep for people with advanced cancer. Out of 28 participants, insomnia severity dropped from 61% at the start of the study to just 18% after a year, while also showing better sleep efficiency and fewer nighttime awakenings. This matters because better sleep can improve mood, quality of life, and overall well-being for patients dealing with advanced cancer. Who this helps: This research benefits patients with advanced cancer, particularly those struggling with insomnia.

Plain English
This study looked at 201 patients with a serious form of blood cancer called extramedullary multiple myeloma (EMM) from 2010 to 2023. The researchers found that while some patients with EMM had survival rates similar to those with regular multiple myeloma, those with primary or secondary plasma cell leukemia had much lower survival rates—only 26 months and 1.6 months, respectively. Understanding the different outcomes based on other factors is crucial for improving treatment and care options for these patients. Who this helps: This helps patients with multiple myeloma, especially those diagnosed with EMM or plasma cell leukemia.

Plain English
This study looked at using multiple rods (three or more) in spine surgery, which is becoming more common because it helps improve surgical outcomes. Specifically, it found that using these multirod systems leads to a lower rate of complications like rod fractures and the need for repeat surgeries compared to the traditional two-rod systems. This is important because it can lead to better recovery and long-term results for patients undergoing complex spine surgeries. Who this helps: Patients undergoing complex spine surgery.

Plain English
This study looked at 38 patients who suffered serious spinal injuries from bullets between 2018 and 2022. The researchers found that the likelihood of having neurological issues was higher in patients with specific injuries, such as those with bone or metal fragments inside the spinal canal. Although surgery was performed on some patients, it did not show a clear improvement in their neurological conditions. Who this helps: This information benefits doctors and surgeons treating patients with gunshot-related spinal injuries.

Plain English
This study tested a combination of three drugs—bortezomib, sorafenib, and decitabine—to see if it could improve treatment for patients with acute myeloid leukemia (AML). Out of the 15 patients treated, one-third (33.3%) showed a positive response to the treatment, with some experiencing notable increases in a specific microRNA (miR-29b) that may help boost the effects of decitabine. The treatment was generally safe, although some patients experienced significant side effects like high blood pressure and fever-related complications. Who this helps: This research benefits patients with newly diagnosed or difficult-to-treat AML.

Plain English
Researchers created a new group of compounds called spiroisoxazolines to see how effective they are at fighting infections. They tested these compounds against different types of bacteria and yeast, and found that two of them showed strong antibacterial effects, with one able to inhibit bacterial growth at a concentration similar to that of a commonly used antibiotic. This is important because these findings suggest that these new compounds could lead to better treatments for infections, especially in an era of rising antibiotic resistance. Who this helps: This benefits patients who are suffering from bacterial and fungal infections.

Plain English
This study looked at the long-term effects of CAR T-cell therapy in patients with difficult-to-treat blood cancers, tracking 246 patients for an average of about three years. It found that 8.5% of patients developed a second cancer after treatment, with most cases being non-melanoma skin cancers (52%) and some developing serious blood cancers again (33%). This is important because it highlights the need for ongoing monitoring of patients who have undergone CAR-T therapy to catch any new cancers early. Who this helps: This helps patients who have received CAR-T therapy, as well as their doctors.

Plain English
This study looked at injuries to the lower spine caused by gunshot wounds in civilian patients. Researchers analyzed 148 patients and found that certain types of spinal fractures, like those involving the pedicle and lamina, significantly increase the risk of neurological problems, with a strong predictive model achieving a high accuracy rate of about 85%. Understanding these injury patterns is crucial because it helps doctors identify which patients are at higher risk for neurological deficits based on their specific spinal injuries. Who this helps: This helps doctors in trauma centers better assess and treat patients with gunshot wounds to the spine.

Plain English
This study looked at how long and how much opioid medication patients used after having a less invasive surgery for lower back pain called minimally invasive sacroiliac joint fusion (MIS SIJF). Researchers found that a year after this surgery, 73% of patients who used opioids regularly before their surgery continued taking them, compared to only 49-62% of patients who had other spine surgeries. This matters because it highlights that patients who underwent MIS SIJF might need more opioid pain relief than those who had different types of spine surgeries, suggesting that this surgery may not reduce pain as effectively. Who this helps: This helps patients recovering from minimally invasive spine surgeries.

Plain English
This study looked at lung issues in people who have had COVID-19 and continue to experience symptoms like cough and trouble breathing, commonly known as pulmonary Long COVID. Out of 929 patients, 51% showed significant lung problems, with 11 times higher risk if they needed mechanical ventilation during their COVID-19 infection. Understanding these patterns is crucial for better diagnosing and treating patients with these ongoing respiratory issues. Who this helps: This helps patients suffering from Long COVID and their doctors in managing their recovery.

Plain English
This study looked at 1,097 patients with long COVID who experienced ongoing lung symptoms like cough and shortness of breath for more than a month after recovering from COVID-19. The findings showed that 51% of these patients had significant issues with lung function, specifically diffusion impairment or lung restriction. Notably, those who had needed invasive ventilation during their initial COVID-19 infection were almost ten times more likely to develop these lung problems. Who this helps: This information helps doctors better understand and treat patients with long COVID, particularly those experiencing ongoing lung issues.

Plain English
This study examined how an artificial intelligence (AI) system helps radiologists detect incidental pulmonary embolisms (IPE) during chest or abdomen CT scans. Results showed that when radiologists used the AI, their ability to correctly identify IPE increased significantly, with sensitivity rising from 80% to 96%, although the overall detection rates were similar (1.4% in phase 1 and 1.6% in phase 2). This improvement in detection rates, with no change in time to report results, means that AI can effectively support radiologists in identifying these potentially serious conditions. Who this helps: This benefits patients by improving the chances of catching undetected pulmonary embolisms.

Plain English
This study looked at how multiple myeloma (a type of cancer) cells avoid being attacked by the immune system. Researchers found that a protein called HLA-E helps these cancer cells escape immune detection and that high levels of HLA-E are linked to more aggressive disease features. By blocking another protein called CREB1, which helps produce HLA-E, they were able to make natural killer (NK) cells more effective at targeting and killing cancer cells. This is important because improving the ability of the immune system to attack cancer can lead to better treatment outcomes for patients. Who this helps: This helps patients with multiple myeloma.

Plain English
This study examined how patients with low-velocity gunshot injuries to the pelvis were treated and the outcomes they experienced. Researchers looked at 156 patients, mostly young men around 30 years old, finding that 70.5% had multiple gunshot wounds, and many suffered additional injuries, including intestinal damage in 50.6% of cases. The findings indicate that certain factors, like having diabetes or suffering neurological injuries, significantly increase the risk of complications after the injury, which is important for doctors making treatment decisions. Who this helps: This helps patients and doctors by identifying risks associated with pelvic bullet injuries.

Plain English
This study looked at the effects of two different versions of the chemotherapy drug melphalan used before a type of stem cell transplant in patients with a blood cancer called multiple myeloma. Researchers compared outcomes from 259 patients treated with a newer melphalan formulation (PGF-mel) to 255 patients who received the standard version (PG-mel). They found that while the relapse rates were similar for both groups, PG-mel led to more serious side effects and required longer hospital stays, but ultimately the hospital decided to continue using PG-mel as the preferred option due to overall treatment responses and costs. Who this helps: This helps doctors and patients with multiple myeloma as they choose treatment options.

Plain English
This study looked at the outcomes of a second stem cell transplant (called salvage autologous hematopoietic cell transplantation or sAHCT2) for patients whose multiple myeloma came back or didn’t respond to previous treatments. Out of 57 patients, 81% achieved a complete or very good partial response after the second transplant, with an average progression-free survival (time without the disease getting worse) of 1.6 years and overall survival (time until death) of 3.6 years. This research is important because it shows that sAHCT2 can be a safe and effective treatment option for patients who have already had one transplant. Who this helps: This helps patients with relapsed or refractory multiple myeloma looking for effective treatment options.

Plain English
This study looked at how a condition called monoclonal gammopathy of undetermined significance (MGUS) can progress into multiple myeloma (MM), a type of blood cancer. The researchers analyzed genetic data from 101 MGUS patients and 383 MM patients, finding specific genes and pathways that are important for the development of these conditions. They identified certain genes linked to MGUS and found others, like DUSP4 and LAMP5, that are more active in MM, which could help in spotting patients at risk of worsening and may lead to new treatments. Who this helps: This helps patients with MGUS and doctors who monitor their condition.

Plain English
This study looked at multiple myeloma (MM) patients who had stem cell transplants and found that 26% of them experienced disease progression between the end of their initial treatment and the transplant day. Specifically, for those treated with a certain therapy, progression was linked to worse outcomes regarding how long they remained free of disease after the transplant. This finding highlights the need for better management strategies for patients who experience such progression. Who this helps: This research benefits doctors and healthcare teams focused on treating patients with multiple myeloma.

Plain English
This study looked at a new type of heart patch made from living cells to help heal damaged hearts in pigs with chronic heart failure. After using the patch for six months, the pigs showed better heart function, increased ability to exercise, and no serious side effects, which indicates that the patch may improve recovery from heart damage. This matters because it offers a promising new approach to treating a condition that affects millions of people with currently no effective treatment focused on healing the heart itself. Who this helps: Patients with chronic heart failure.

Plain English
This study examined the role of a protein called CD56 in multiple myeloma, a type of blood cancer. The researchers found that about 70% of patients have high levels of CD56 in their cancer cells, and those with more than 10% of these cells tend to have worse outcomes. By blocking certain pathways related to CD56, they were able to kill these cancer cells, particularly when combined with a drug called lenalidomide, which can be less effective in patients with high CD56 levels. Who this helps: This helps patients with multiple myeloma and their doctors by providing new targets for treatment and improving the effectiveness of existing therapies.

Plain English
This paper looks at new treatments for problems with blood vessels, particularly the tiny ones that supply organs and tissues. Researchers found that various therapies using cells and tiny particles released from cells (called exosomes) can improve blood flow and tissue health. For example, these methods may address multiple factors that disrupt blood vessel function, offering a more complete solution to vascular issues rather than just treating symptoms. Who this helps: This helps patients with conditions that affect blood flow, such as those with heart disease or diabetes.

Plain English
This study looked at how inflammation during pregnancy, specifically chorioamnionitis, affects lung development in preterm babies. Researchers found that inflammation damaged the lung's gas exchange surface, leading to structural issues similar to chronic lung disease, but treatment that blocked certain inflammatory signals helped protect and restore lung structure. This research is important because it highlights a potential way to prevent lung damage in preterm infants caused by inflammation during pregnancy. Who this helps: This helps preterm infants at risk of lung disease due to maternal inflammation.

Plain English
This study looked at 26 patients who had T-cell lymphoma and also had a related condition called plasma cell dyscrasia (PCD). The researchers found that treatment for the T-cell cancer worked well for most patients, but those with peripheral T-cell lymphoma (PTCL) and PCD had much worse outcomes, with a survival time of just 1.7 years. This matters because understanding these differences helps doctors treat patients more effectively and monitor them better. Who this helps: Patients with T-cell malignancies and their doctors.